Overview

OTC Naproxen and Acetaminophen Anti-Inflammatory Action in Dental Implant Patients

Status:
Recruiting
Trial end date:
2022-04-06
Target enrollment:
Participant gender:
Summary
This double-blind pilot study will evaluate the anti-inflammatory and analgesic effects of an over-the-counter (OTC) regimen of naproxen sodium versus acetaminophen in patients receiving one or two (adjacent) dental implants. It will also confirm that naproxen sodium in the OTC dosage range is a good alternative to immediate-release opioid formulations, which are subject to misuse, abuse and diversion in this patient population.
Phase:
Phase 4
Details
Lead Sponsor:
Hersh, Elliot V., DMD, MS, PhD
Collaborators:
Bayer
University of Pennsylvania
Treatments:
Acetaminophen
Naproxen
Tramadol